Investment Summary

1315 Capital Invests In Onkos Surgical

On October 6, 2015, growth capital firm 1315 Capital invested in medical products company Onkos Surgical

Investment Highlights
  • This is 1315 Capital’s 3rd transaction in the Medical Products sector.
  • This is 1315 Capital’s 3rd transaction in the United States.
  • This is 1315 Capital’s 1st transaction in New Jersey.

Investment Summary

Date 2015-10-06
Target Onkos Surgical
Sector Medical Products
Investor(s) 1315 Capital
Deal Type Venture

Target

Onkos Surgical

Parsippany, New Jersey, United States
Onkos Surgical is a privately held surgical oncology start-up. Onkos Surgical believes surgical oncology deserves attention, focus and innovation. Through dedication and strategic partnerships, Onkos Surgical will advance surgical oncology solutions and will advocate for and support the surgeons and caregivers that dedicate their lives to the surgical treatment of cancer. Onkos Surgical was founded in 2015 and is based in Parsippany, New Jersey.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

DESCRIPTION

1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $40 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.


DEAL STATS #
Overall 3 of 21
Sector (Medical Products) 3 of 7
Type (Venture) 2 of 6
State (New Jersey) 1 of 3
Country (United States) 3 of 19
Year (2015) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-01-01 CHC Solutions

Pittsburgh, Pennsylvania, United States

CHC Solutions is an innovative and energetic home medical equipment and supply company. The company have taken on the challenge of meeting the home medical equipment, supply, and service needs of those requiring care in the home. The company service Philadelphia and the five surrounding counties as well as New Jersey and Delaware. CHC Solutions is based in Pittsburgh, Pennsylvania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-22 JDS Therapeutics

Purchase, New York, United States

JDS Therapeutics is a specialty pharmaceutical company that develops, manufactures and markets products for women’s health. JDS’s wholly-owned subsidiary, Nutrition 21, is a leader in the nutritional supplement industry. Nutrition 21 is a developer and marketer of efficacious, highvalue, clinically substantiated ingredients for dietary supplements, medical foods and beverages, including Chromax® chromium picolinate and Nitrosigine® bonded arginine silicate. JDS and Nutrition 21 currently hold over 100 issued and pending patents on natural, bioactive compounds that support human health and sports nutrition. JDS Therapeutics was founded in 2011 and is based in Purchase, New York.

Buy -